Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

11.93
Delayed Data
As of Feb 26
 +0.13 / +1.10%
Today’s Change
10.85
Today|||52-Week Range
18.48
-15.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Operating ActivitiesNet Income / Starting Line-20.5M-28.1M-22.7M-46.7M
 
 
 
 
 
Depreciation60.0K47.0K35.0K54.0K
 
 
 
 
 
Total Other Cash Flow2.6M1.8M2.2M5.9M
 
 
 
 
 
Funds From Operations-17.8M-26.2M-20.5M-40.8M
 
 
 
 
 
Extraordinary Items0.000.00-2.6M--
 
 
Funds From/For Other Operating Expenses-1.6M-3.4M1.6M-6.5M
 
 
 
 
 
Net Cash Flow - Operating Activities-16.2M-22.8M-24.8M-34.3M
 
 
 
 
 
 
InvestingIncrease In Investments-18.4M-9.9M-11.3M-24.4M
 
 
 
 
 
Decrease In Investments37.4M5.8M15.5M24.4M
 
 
 
 
 
Capital Expenditures-23.0K-57.0K-24.0K-346.0K
 
 
 
 
 
Net Cash Flow Investing19.0M-4.2M4.2M-346.0K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale9.2M33.8M0.0075.7M
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing9.2M33.8M0.0075.7M
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----0.000.00--
 
Net Change In Cash12.0M6.8M-20.6M41.0M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account